Results 51 to 60 of about 1,168 (170)

Spectrum of Pituitary disorders: A retrospective study from Basrah, Iraq [version 2; referees: 2 approved]

F1000Research, 2018
Background: Pituitary disorders spectrum includes a wide variety of diseases.This study aimed at a comprehensive description of such disorders for patients from  Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) in Basrah (Southern Iraq)
Abbas Ali Mansour, Ali Hussain Ali Alhamza, Ammar Mohammed Saeed Abdullah Almomin, Ibrahim Abbood Zaboon, Nassar Taha Yaseen Alibrahim, Rudha Naser Hussein, Muayad Baheer Kadhim, Haider Ayad Yassin Alidrisi, Hussein Ali Nwayyir, Adel Gassab Mohammed, Dheyaa Kadhim Al-Waeli, Ibrahim Hani Hussein   +11 more
doaj   +1 more source

Efficacy and safety of endoscopic transsphenoidal resection for prolactinoma: a retrospective multicenter case-series [PDF]

, 2023
Background: Endoscopic transsphenoidal surgery (ETSS) for prolactinoma is reserved for dopamine agonist (DA) resistance, intolerance, or apoplexy. High remission (overall 67%, microprolactinoma up to 90%), low recurrence (5-20%) rates highlighted that ...
Bakker, L.E.H., White, T.G., Pelsma, I.C.M., Prevedello, D.M., Zandbergen, I.M., Ghalib, L.M., Biermasz, N.R., Furth, W.R.V., Verstegen, M.J.T., Dehdashti, A.R., Huntoon, K.M.   +10 more
core   +2 more sources

Cabergoline Therapy in Giant Prolactinoma With Secondary Apoplexy: A Case Report [PDF]

, 2022
Pituitary apoplexy (PA) is a rare, potentially life-threatening clinical syndrome resulting from acute infarction or hemorrhage of the pituitary gland1.
Paul Kay; Kimberly Winges
core  

Giant prolactinoma: case report [PDF]

Objective: To report the clinical case of an adolescent with a giant prolactinoma, diagnosed at the pediatric endocrinology service of a public university hospital in Salvador, Bahia.
Ferreira, Juliane Moreira
core   +1 more source

Atypical giant prolactinoma with frontal lobe manifestations. [PDF]

BMJ Case Rep, 2018
Prolactinomas having the diameter above 4 cm are termed ‘giant prolactinomas’.1 2 Their incidence is approximately 2%–3% of all prolactinomas1. These are associated with very high prolactin concentration and numerous neurological sequelae, arising from their extension into surrounding structures.
Arshad MF, Arambewela M, Debono M.
europepmc   +4 more sources

The importance of measuring prolactin prior to surgical management of a pituitary lesion: An illustrative case

Radiology Case Reports, 2023
The characterization of sellar and suprasellar lesions is reliant on patient presentation, medical imaging, and hormone profiling. Prolactinomas are the most common type of functional pituitary adenomas, accounting for up to 57%.
Nikita Ollen-Bittle, MSc, Donald Lee, MD, Alain Proulx, MD, MSc, Neil Duggal, MD, MSc, Stan H.M. Van Uum, MD, PhD   +4 more
doaj   +1 more source

Very Long‐Term Follow‐Up of Multidimensional Health‐Related Quality of Life After Endoscopic Endonasal Surgery for Pituitary Adenomas: A Prospective Cohort Study

Head &Neck, Volume 48, Issue 4, Page 1088-1096, April 2026.
ABSTRACT Background To evaluate postoperative health‐related quality of life (HRQoL) for pituitary adenoma patients, multidimensional assessment is important. Available data is limited on long‐term follow‐up. Methods Prospectively, 52 nonfunctioning (NFA) and functioning (FA) pituitary adenoma patients were included.
Gonneke E. Joustra, Nathalie F. van Rhee, Marc C. den Heijer, Astrid G. W. Korsten‐Meijer, Robert A. Feijen, György B. Halmos, Jos M. A. Kuijlen, Karin M. Vermeulen   +7 more
wiley   +1 more source

GIANT PROLACTINOMA IN A PATIENT WITH GERMLINE SDHB MUTATION. [PDF]

Acta Endocrinol (Buchar)
Rocha JV, Amaro E, Gomes A, Bugalho MJ.
europepmc   +3 more sources

Adrenal Crisis Induced by Zoledronic Acid in Two Patients With Hypopituitarism: A Case Report and Literature Review

Case Reports in Endocrinology, Volume 2026, Issue 1, 2026.
Adrenal insufficiency (AI) is characterized by inadequate steroid hormone production and is frequently a consequence of hypopituitarism, which is also associated with increased risk of osteoporosis due to deficiencies in growth hormone, gonadotropins, and other pituitary hormones.
Abrar Mohammed AlFaifi, Wael Mohammad AlMistehi, Osamu Isozaki   +2 more
wiley   +1 more source

Somatostatin Receptor Scintigraphy of a Patient with a Giant Invasive Prolactinoma [PDF]

, 1999
SummaryA 41-year-old with a giant prolactinoma underwent ln-111 pentetreotide (Octreotide) imaging showing very intense tracer uptake in the region of the anterior skull base.
N. I. Bohnen, B. Shapiro, P. Meyer, A. L. Barkan   +3 more
core   +1 more source